Business:
Positive Functional Modulators disease-modifying precision therapeutics that restore ABC transporter function
About:
Rectify Pharmaceuticals is developing therapeutics that restore the function of ABC transporters. ABC transporters include a family of proteins that actively export a diverse range of substrates across lipid membranes, with their disruption linked to various serious diseases. Through the use of their breakthrough ABC-transporter product platform, Rectify is efficiently and rapidly discovering first-in-class small molecule therapies that can restore ABC transporter function for rare and common diseases.